about
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating ...
Read More
59.01
-2.06
(-3.37%)
530.9K
XNYS Volume
XNYS 18 Mar, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
No Score Avaliable
Veradermics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..